Braskem (BAK) Accumulated Expenses (2009 - 2025)

Braskem (BAK) has reported Accumulated Expenses for 17 consecutive years, with $150.2 million the latest figure, recorded in Q4 2025.

• Quarterly Accumulated Expenses fell 15.48% year-over-year to $150.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $150.2 million (down 15.48% YoY) and the FY2025 annual result came in at $150.2 million, down 15.48% from the prior year.
• Accumulated Expenses grew to $150.2 million in Q4 2025 per BAK's latest filing, from $120.1 million in the prior quarter.
• Over the last five years, Accumulated Expenses for BAK reached as high as $209.8 million in Q4 2021 and fell as low as $120.1 million in Q1 2025.
• A 5-year average of $164.9 million and a median of $162.3 million in 2022 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2021 — Accumulated Expenses jumped 39.07% — and 2022, when it slipped 24.99%.
• Year by year, Accumulated Expenses stood at $209.8 million in 2021, then retreated by 24.99% to $157.4 million in 2022, then advanced by 6.27% to $167.3 million in 2023, then gained by 6.28% to $177.7 million in 2024, then fell by 15.48% to $150.2 million in 2025.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $150.2 million, $120.1 million, and $177.7 million for Q4 2025, Q1 2025, and Q4 2024 respectively.